United States Minimally Invasive Surgery Device Market Size

US Minimally Invasive Surgery Device Market Analysis

The US minimally invasive surgery device market is expected to register a CAGR of 6.4% over the forecast period.

• The COVID-19 pandemic has had an impact on the US minimally invasive surgery device market initially. The market experienced a moderate decline in growth during the pandemic. It was primarily due to the temporary cancellation of treatment and elective procedures and patient visits to the hospitals for the management of chronic diseases other than COVID-19. The pandemic shifted most of the focus of healthcare and research on COVID-19-related diagnosis and patient care, adversely impacting the country's other medical care areas. For instance, in a study published in the Spine Journal by a researcher at NYU Langone Health, the United States, in December 2021, over one-third of elective spinal surgeries got canceled due to the pandemic. However, in the post-pandemic period, the lifting of the lockdown and gradual resumption of the treatment and patient care for the non-COVID medical areas are expected to restore the normal growth rate of the market. For instance, in a study published in the Annals of Medicine and Surgery by the researchers of the University of California San Diego and Rady Children's Hospital, San Diego, in September 2022, the same-day surgery cancellation decreased after the pandemic. The study hypothesized that the required pre-operative COVID diagnosis enabled healthcare providers to reduce the number of surgery cancellations and meet the requirement of the patients. The market is expected to grow further at a stable pace with the increasing demand for minimally invasive surgical devices in the United States.
• The market is expected to grow with a higher acceptance rate of minimally invasive surgeries over traditional surgeries, increasing prevalence of lifestyle-related and chronic disorders, and technological advancements. The prevalence of chronic diseases is on the rise in the United States, which is expected to create more demand for minimally invasive surgical devices for the management of diseases. For instance, according to data published by the CRT Group Foundation in August 2022, the number of individuals living with hypertension will increase by 27.2% to 162.5 million from 127.8 million during the period of 2025 to 2060. As per the data published by the US Census Bureau in November 2022, more than 34 million adults live with diabetes in the United States, and 88 million more individuals are at risk of developing the disease. Several studies have underlined the advantage of minimally invasive surgical devices, which promotes the adoption of these devices for performing surgical interventions. 
• A study published in the Frontiers in Robotics and AI by researchers of New York University in January 2022 highlighted the advantages offered by minimally invasive surgical devices, such as shorter hospital stays, decreased postoperative pain, better and faster recovery, and decreased learning curve for the surgical trainees. As per a study published in the JAMA Network by researchers from the United States in September 2022, minimally invasive nephrectomy showcased better efficacy and cost-effectiveness. Thus, with the increasing number of chronic diseases, the advantage of minimally invasive surgeries and devices, and the demand for minimally invasive surgical devices, the market is expected to grow further during the forecast period in the United States.
• Therefore, owing to the aforementioned factors, the market studied is anticipated to witness growth over the analysis period. However, the shortage of experienced professionals and uncertain regulatory frameworks are likely to impede the market's growth.